CN102627767B - Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof - Google Patents
Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof Download PDFInfo
- Publication number
- CN102627767B CN102627767B CN 201210087875 CN201210087875A CN102627767B CN 102627767 B CN102627767 B CN 102627767B CN 201210087875 CN201210087875 CN 201210087875 CN 201210087875 A CN201210087875 A CN 201210087875A CN 102627767 B CN102627767 B CN 102627767B
- Authority
- CN
- China
- Prior art keywords
- parts
- macromonomer
- solvent
- poly
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention discloses a potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and a preparation method and application thereof. Firstly, polylactic acid with two ends sealed with hydroxide radicals is synthesized through a solution polymerization method, propylene serves as a macro-monomer after acidification, and a pH response amphiphilic copolymer is prepared through the Michael gradual addition reaction. The proportion of functional groups in the polymer molecule can be regulated. The synthetic process is simple, and the production rate is high. By means of a polymeric micelle obtained through a dialysis method and with a hydrophobic group (polylactic acid) and a pH response group (poly-beta amino ester) forming a kernel and a hydrophilic group forming acasing, water slight-solubility anti-cancer drugs can be coated into the kernel of the micelle, and the drugs can be slowly released in low quantity under neutral or weak alkaline conditions and can be quickly and controllably released under weakly acidic conditions.
Description
Technical field
The present invention relates to biological medicine and use the macromolecule polymer material field, be specifically related to a kind of based on poly--
βPH response random copolymers and method for making and the application of amino ester.
Background technology
Cancer becomes the main killer of harm humans life and health day by day, and chemotherapy is most important effective treatment means except operation.But there is following two large problems: the one, the toxic side effect of medicine; The 2nd, the resistance of tumour (cancer cells).Though a lot of cancer therapy drugs can be treated cancer on pharmacology, yet, because the hydrophobic or poorly water-soluble (as Zorubicin, camptothecine, taxol etc.) of medicine influences result for the treatment of clinically,, thereby still face huge challenge for the application of this kind anti-cancer drugs thing.
The nano core-shell structure micella that is formed by amphipathic multipolymer is made the carrier of slightly water-soluble cancer therapy drug, can control the release of medicine.Have lot of advantages, can improve the apparent water-soluble of medicine as it; Provide passive and active target ability, avoid engulfing or being absorbed by tissues such as liver spleens of the interior reticuloendothelial system (RES) of body, thereby be conducive to prolong micella in blood cycling time and in the accumulation at tumor tissues position, improve medicine in the activity of privileged site, thereby effectively improve drug effect, reduce side effect.In addition, polymer micelle has lower micelle-forming concentration, bigger solubilising space, Stability Analysis of Structures, and the different properties according to the polymer hydrophobic segment can have tangible solubilizing effect to poorly water soluble drugs by effect packaging medicines such as chemistry, physics and static.
The cancer therapy drug medicine-carried system of a success must have higher pharmaceutical pack carrying capacity, longer steady state in blood of human body circulation environment, and good target function, toxic side effect is little, characteristics such as good biocompatibility.PH responsive polymer micella is owing to can keep dense structure under the normal pH environment of human body, reduce the seepage of medicine, and at weakly acidic condition (tumour cell) thus swelling taking place down or dissociates promotes that medicine discharges fast, thereby be considered to the ideal carrier of insoluble cancer therapy drug targeted therapy.The pH value of healthy tissues is generally 7.4.The anoxic condition of solid tumor inside makes tumour cell anaerobic glycolysis produce lactic acid, and the shortage of inside tumor vascular system can not fully be discharged the lactic acid of generation, causes solid tumor inside to have different sour environments, as the weak acid environment pH in the tenuigenin
E7.06 about, the acidity in endosome and the lysosome is stronger, and generally about 5.0, lysosomal pH value is 4.0-5.0 to the pH value of early stage endosome.The sour environment of tumour can be used as the quick medicament release that signal is used for triggering carrier micelle, promotes cell endocytic micella and organoid target thereof.
When pH changed, the ionization state of the weakly alkaline polymkeric substance of basic groups such as band amido, pyridine or imidazolyl or the slightly acidic polymkeric substance of band carboxylic group changed, and causes its solvability in water to change.Weakly alkaline polymer poly (N commonly used, N-diethyl amido ethyl-methyl acrylate) [poly (N, N-diethylaminoethyl methacrylate), PDEA], poly-(4-vinylpridine) [poly (4-vinylpyridine), PVP], polyhistidyl [poly (L-histidine), Phis] and poly-(
β-amido ester) [poly (
β-amino esters)] etc. water insoluble under alkalescence or neutrallty condition; and under acidic conditions; because basic group takes place protonated and positively charged; take place to change mutually; cause that its micellar structure changes; thereby realize that medicine-carried system keeps stable under home, and release efficiency is preferably arranged in that weak acid pH environment is next, so can be used as the carrier of insoluble cancer therapy drug targeted therapy.
That Langer [J. Am. Chem. Soc. 2000,122,10761] has synthesized a series of novel degradables is poly--
βAmino ester (PAE) is used for the transmission of DNA, and PAE issues unboiled water solution generation 1,4-butyleneglycol and amino acid in acid or alkaline condition, compares with PEI, and PAE and hydrolysate thereof are nontoxic substantially.The microballoon of PAE also is used for water soluble medicament-entrapping, keep medicine stablizing under extracellular and tenuigenin pH environment, and under endosome and lysosome pH environment, discharge, medicine enters tenuigenin and then performance drug effect [Angewandte Chemie-International Edition again from endosome or lysosome, 2001,40,1707].Add PEG in the process of preparation PAE microballoon, form the PAE nanoparticle that PEG modifies, the bag that is used for taxol carries and discharges, and can obviously alleviate the prominent phenomenon of releasing, and improving release efficiency Journal of Controlled Release, 2003,86,223].Patent application KR2009056478-A has announced a kind of degradable polymer of being made up of urethane derivative main chain and pH responsiveness side chain, it can pass through the form of micella or gel as the carrier of components such as medicine, polypeptide, nucleic acid, protein, is used for tumour, inflammation and other treatment of diseases.LEE [Journal of Controlled Release, 2007,123,109] synthetic bi-block copolymer MPEG-PAE bag carries Zorubicin DOX, extracorporeal releasing experiment shows, this material is the good carrier of insoluble cancer therapy drug targeted therapy tumour, and to release phenomenon serious but medicine is prominent, and controlled-release effect is undesirable.Patent application CN102295737-A has announced the preparation method of multiple response amphiphilic polyurethane materials such as a kind of pH of having, temperature and light.Patent application WO2010018286-A1, ES2333087-A1 have announced the micella that a kind of branch-shape polymer by the polyoxyethylene glycol connection and linear polyhistidyl form by electrostatic interaction, and it is used for the carrier of medicine and diagnostic reagent.By changing environment PH the electrically charged character of polyhistidyl is changed, the bag of regulation and control MICELLAR STRUCTURE realization pH response carries and discharges.Patent application US2005070721-A1, US7229973-B2 have announced a kind of mixed micelle by polylactic acid-polyglycol and the preparation of polyethylene glycol-Histidine, and have shown that this micella has the tumor-targeting function of pH response.Patent application CN102268137-A has announced the preparation method of a kind of star poly(lactic acid)-polymethyl acrylic acid dimethylaminoethyl segmented copolymer, and points out to wrap a year hydrophobicity chemotherapeutics, is used for treatment for cancer.
Report from existing research how effectively to improve drug loading and alleviation or eliminate the prominent phenomenon of releasing; How to improve medicine-carried system the response accuracy that environment pH changes is also controlled the efficient that discharges, be still current two topmost difficult problems that face.Common micelle medicine carrying system, drug-loaded layer and pH response layer have certain space length, make that the such process of pH response-micella swelling-drug release of micella is slow, accurate and sensitive inadequately to the response that environment pH changes, if respond group and increase too much pH, its medicine carrying ability is descended, and prominently release phenomenon and also can aggravate.
Summary of the invention
For the bag of the stability that effectively improves the micelle medicine carrying delivery system, pH response sensitivity, medicine carries efficient and control release performance, the present invention design synthetic a kind of based on poly--
βPH response linear random copolymer of amino ester and its preparation method and application, its self-assembled micelle is used for the targeted drug delivery system of slightly water-soluble cancer therapy drug.
General plotting of the present invention is as follows: hydrophobic material PLA and pH responsive materials PAE are designed to the random copolymerization block, form the bi-block copolymer material with hydrophilic block again.The amphipathic nature polyalcohol molecular structure of this pH response/hydrophobic grouping random copolymerization can increase pH response region in its self-assembled micelle, improve drug loading, make pH response-micella swelling-drug release be rendered as a synchronous process, thereby improve pH response sensitivity and the release efficiency of micella, improve the controlled release properties of micelle medicine carrying system, also can effectively alleviate prominent releasing simultaneously.Hydrophilic block forms the micella shell, is conducive to micella stability, strengthens anti-albumen and thrombocyte adsorptive power, prolongs micella cycling time in vivo.Behind the carrier micelle drug administration by injection, in normal human's environment because that hydrophobic material PLA and pH response block PAE is all is hydrophobic, the micella kernel closely, Stability Analysis of Structures, release amount of medicine is few.Along with pH changes, arrive under the solutions of weak acidity, PAE is protonated, and micellar surface becomes positively charged, is conducive to enter tumour cell by cytolemma, and the protonated micella generation swelling that makes of PAE, drug release rate is accelerated.Can adapt to different release requests by the content of pH response block in the telomerized polymer material.
The present invention is achieved through the following technical solutions: earlier synthetic two ends envelope hydroxyl macromonomer, again with the monomer acrylated, utilize progressively addition reaction of Michael subsequently, and namely obtain pH response amphipathic nature polyalcohol material.The self-assembly in the aqueous solution of this polymer molecule is nano-micelle, and effectively bag carries poorly water soluble drugs.
The object of the invention is achieved through the following technical solutions:
A kind of based on poly--
βThe pH response random copolymers of amino ester, structural formula is
x=2~10，y=1~6，n=113。
The number-average molecular weight of described multipolymer is 10752 ~ 14536 g/mol.
Described a kind of based on poly--
βThe molecular formula of the pH response linear random copolymer of amino ester is: MPEG-
b-(PLA-
Co-PAE).
Described based on poly--
βThe preparation method of the pH response random copolymers of amino ester may further comprise the steps:
(1) preparation macromonomer A: under protection of inert gas and anhydrous condition, with monomer, catalyst system A, initiator and solvent, at 80 ~ 120 ℃ of reaction 12 ~ 36 h down, remove solvent after, precipitation, filtration, drying obtain macromonomer A;
(2) preparation macromonomer B: macromonomer A is dissolved in the solvent, add reductive agent, be cooled to 0 ℃, add acylating agent then, keep 0 ℃ to rise to behind reaction 2 h down and react 12 ~ 36 h under the room temperature again, then the macromonomer B after precipitation, filtration, dry terminal hydroxyl acrylated;
(3) preparation macromonomer D: hydrophilic macromonomer C is dissolved in the solvent, add reductive agent, be cooled to 0 ℃, add acylating agent then, keep 0 ℃ to rise to behind reaction 2 h down and react 12 ~ 36 h under the room temperature again, then the macromonomer D after precipitation, filtration, dry terminal hydroxyl acrylated;
(4) preparation based on poly--
βThe pH response linear random copolymer of amino ester: the macromonomer B that respectively macromonomer D, diacrylate, diamines and step (2) is obtained under protection of inert gas and anhydrous condition is dissolved in the solvent, the mixing back is reacted 60 ~ 80 h down at 50 ~ 80 ℃, and precipitation, filtration, oven dry obtain pH response linear random copolymer;
The parts by weight of reactant are as follows in the described step (1):
84.7 ~ 98.04 parts of monomers
0.33 ~ 2.6 part of catalyst system A
1.62 ~ 12.7 parts of initiators;
The parts by weight of reactant are as follows in the described step (2):
61 ~ 91.32 parts of macromonomer A
4.8 ~ 17 parts of reductive agents
4.13 ~ 23.68 parts of acylating agents;
The parts by weight of reactant are as follows in the described step (3):
90.9 ~ 96.2 parts of hydrophilic macromonomer C
1.9 ~ 5.45 parts of reductive agents
1.9 ~ 3.35 parts of acylating agents;
The parts by weight of reactant are as follows in the described step (4):
20.36 ~ 41.81 parts of macromonomer D
9.8 ~ 25.57 parts of diacrylates
12.96 ~ 31.45 parts of diamines
16.72 ~ 42.25 parts of macromonomer B.
Described monomer is D, the L-rac-Lactide;
Described diamines is 1,3-pair-4-piperidines propane;
Described diacrylate is 1,6 hexanediol diacrylate;
Described hydrophilic macromonomer C is mono methoxy polyethylene glycol, and its structural formula is as follows:
N=113 wherein.
Catalyst system A is the toluene solution of stannous octoate described in the step (1);
The described initiator of step (1) is 1,4-butyleneglycol;
The described solvent of step (1) is toluene or methyl-phenoxide; The amount of solvent is enough to the reactant of dissolving step (1)
Step (2) and (3) described reductive agent are triethylamine;
Step (2) and (3) described acylating agent are acrylate chloride;
Step (2) and (3) described solvent are methylene dichloride;
The described solvent of step (4) is chloroform.
Step (1) is described, and to remove solvent be with the reaction product rotary evaporation desolventizing of reducing pressure;
Precipitation described in the step (1) is that the product that will remove behind the solvent is dissolved in chloroform or the methylene dichloride, solution is joined in the mixing solutions of 0 ℃ of cold methanol being equivalent to 10 times of its volumes and water again, and cold methanol and water volume ratio are 1:1;
Step (2) and (3) described precipitation are that reacted solution is joined in the 0 ℃ of cold normal hexane that is equivalent to 10 times of its volumes; Preferably reacted solution is added hydrochloric acid, gained lower floor solution joins in the 0 ℃ of cold normal hexane that is equivalent to 10 times of lower floor's liquor capacities.
The described precipitation of step (4) is that reacted solution is joined in the 0 ℃ of cold diethyl ether that is equivalent to 10 times of its volumes.
The micelle medicine carrying system of the described poorly water soluble drugs that makes based on the pH response random copolymers of poly--β amino ester.
The preparation method of the micelle medicine carrying system of described poorly water soluble drugs, be with based on poly--
βPH response random copolymers and the poorly water soluble drugs of amino ester are dissolved in the organic solvent, stir behind 6 h with the pH damping fluid 24 h postlyophilizations of dialysing, obtain, described organic solvent is dimethyl formamide or dimethyl sulfoxide (DMSO) or acetone, and described pH damping fluid is the buffered soln of pH value 7 ~ 9.
The present invention also provides a kind of micelle medicine carrying system of described poorly water soluble drugs to carry and APPLICATION IN TRANSMISSION at the bag of slightly water-soluble cancer therapy drug.
Described poorly water soluble drugs is the medicine that solubleness is less than or equal to 1 g in 1 L water.
The described catalyst system A of step (1) is stannous octoate, and its consumption is 0.33% ~ 3% of hydrophobic monomer quality, is preferably 1% ~ 1.5%;
The described initiator of step (1) is 1,4-butyleneglycol, and its consumption is 1.67% ~ 15% of hydrophobic monomer quality, is preferably 5% ~ 8%;
The described reductive agent of step (2) is triethylamine, and its consumption is 1.2 ~ 4 times of macromonomer A mole number, is preferably 2 ~ 2.8 times;
The described acidylate of step (2) is acrylate chloride, and its consumption is 1.5 ~ 10 times of macromonomer A mole number, is preferably 3 ~ 4 times;
The described reductive agent of step (2) is triethylamine, and its consumption is 1 ~ 3 times of macromonomer E mole number;
The described acidylate of step (2) is acrylate chloride, and its consumption is 1.1 ~ 2.2 times of macromonomer E mole number;
The ratio of the described two kinds of diacrylates of step (3) (A-PLA-A:HDD) is 1/3 ~ 1/6, is preferably 1/4 ~ 1/5;
Temperature of reaction in the described step (1) is preferably 95 ~ 105 ℃, and the reaction times is 20 ~ 24 h;
Described step rises to room temperature in (2), and the reaction times is preferably 20 ~ 24 h;
Temperature of reaction in the described step (3) is preferably 55 ~ 65 ℃, and the reaction times is 70 ~ 75 h.
Described a kind of based on poly--
βThe micelle medicine carrying system of the pH response linear random copolymer of amino ester, can be used for the drug administration by injection mode, regulate and control medicine by tumour cell and normal cell environment pH difference and in normal meta-alkalescence or neutral environment, slowly or not discharging, in weakly acidic tumor environment, faster discharge.
The invention has the beneficial effects as follows: the present invention design synthetic a kind of based on poly--
βPH response linear random copolymer and the self-assembled micelle drug-loading system thereof of amino ester, hydrophobic grouping and pH response group are designed to the random copolymerization form, both can keep than high drug load, can effectively regulate pH responding range in its self-assembled micelle again, make the not only variation of response environment pH value rapidly of micella, and effectively alleviate the prominent drug release of releasing and control.The long hydrophilic block of micella shell can improve micella shell density, strengthens wetting ability, anti-albumen and the thrombocyte adsorptive power of micellar surface, prolongs the cycling time of micella, thereby improves the controlled release properties of micelle medicine carrying system.This micelle medicine carrying system Stability Analysis of Structures in home, the micella kernel is tight, and the cumulative release amount is few, thus the protection medicine.In weakly acidic condition, the micella swelling, drug release rate is accelerated, and because micellar surface has positive electricity, is conducive to it and enters tumour cell by cytolemma.Can come the rate of release of regulating medicine by the content of pH response group and hydrophobic grouping in the telomerized polymer molecular material, satisfy the release request of different pharmaceutical.The critical aggregate concentration of this polymer molecule is lower, only is 1.2 ~ 9.5 mg/L, thereby the stability of its carrier micelle is high.
Description of drawings
Fig. 1 is the building-up reactions formula of macromonomer A.
Fig. 2 is the building-up reactions formula of macromonomer A and hydrophilic macromonomer C acrylated.
Fig. 3 is the reaction formula that obtains the linear copolymerized polymer of pH response amphiphilic.
Fig. 4 is the gel permeation chromatography figure (GPC) of HO-PLA-OA among the embodiment 1, and moving phase is tetrahydrofuran (THF) (THF).
Fig. 5 be HO-PLA-OH among the embodiment 1 proton nmr spectra (
1H NMR), solvent is deuterochloroform (d-CDCl
3).
Fig. 6 be MPEG-A among the embodiment 1 proton nmr spectra (
1H NMR), solvent is deuterochloroform (d-CDCl
3).
Fig. 7 is the 1H NMR spectrum of A-PLA-A among the embodiment 1, and solvent is d-CDCl
3
Fig. 8 is MPEG-among the embodiment 1
b-(PLA-
Co-PAE) GPC elution curve.
Fig. 9 is MPEG-among the embodiment 1
b-(PLA-
Co-PAE)
1H NMR spectrum, solvent is d-CDCl
3
Figure 10 is MPEG-among the embodiment 7
b-(PLA-
Co-PAE) micelle-forming concentration test curve.
Figure 11 is that the particle diameter of embodiment 8 empty micellas is with the pH variation diagram.
Figure 12 is that the current potential of embodiment 8 empty micellas is with the pH variation diagram.
Figure 13 is scanning electron microscope (SEM) figure of carrier micelle among the embodiment 9.
Figure 14 is MPEG-among the embodiment 10
b-(PLA-
Co-PAE) (case study on implementation 1 product) carry the release in vitro curve of Zorubicin micella.
Figure 15 is for implementing 11 empty micellas to the toxicity graphic representation to HepG2.
Figure 16 is carrier micelle in the case study on implementation 11 and the free Zorubicin toxicity graphic representation after to HepG2 effect 24 h.
Figure 17 is carrier micelle in the case study on implementation 11 and the free Zorubicin toxicity graphic representation after to HepG2 effect 48 h.
Embodiment
Content for a better understanding of the present invention is described further below in conjunction with concrete embodiment.The abbreviation contrast of uses such as monomer, catalyzer, initiator is as follows in an embodiment:
| Title | Abbreviation | Title | Abbreviation | ||
| Rac-lactide | | Triethylamine | TEA | ||
| 1,4-butyleneglycol | BDO | | AC | ||
| 1,6 hexanediol diacrylate | HDD | Stannous octoate | Sn(Oct) 2 | ||
| 1,3-pair-4-piperidines propane | TDP | Mono methoxy polyethylene glycol | MPEG |
(1) synthetic HO-PLA-OH(A:B:C=100:5:1, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (20 g, 93.9 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.3 mg, 1.41 parts) and initiator 1,4-butyleneglycol (1 g, 4.69 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 100 ℃ of oil baths, react 24 h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.Pre-product is synthetic as shown in Figure 5.As shown in Figure 4
M n=1998, PDI=1.19.
(2) acrylated of HO-PLA-OH (AB:D:F=10:1:1.36, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(5 g, 80.9 part) be dissolved in the solution that forms 10 % in the methylene dichloride (50 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.5 g, 8.09 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.68 g, 11.01 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 24 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.As shown in Figure 7, pre-product is synthetic.
(3) acrylated of MPEG (hydrophilic macromonomer C:D:F=25:10:7, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 93.63 part, n=45) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.1 g with syringe, 3.75 part), to 0 ℃, under agitation dropwise drip AC(0.07 g, 2.62 parts with ice-cooled), react 2 h down at 0 ℃, after rising to room temperature, continue reaction 24 h, reacted solution adds dilute hydrochloric acid, gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of volumes) and precipitates, filter, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.As shown in Figure 6, pre-product is synthetic.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=20:25:9.05:11.57, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(2.5 g, 38.1 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(0.905 g, 13.79 parts), TDP(1.157 g, 17.63 parts), A-PLA-A(2 g, 30.48 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 65 ℃, magnetic agitation is reacted 70 h.The solution that obtains slowly joins in 0 ℃ of ether of 300 mL (being equivalent to 10 times of volumes) precipitation three times, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtains pale yellow powder.Right Fig. 8 learns and obtains pre-product.As shown in Figure 9
M n=10952, PDI=1.39.Obtain the x=7 of product, y=1, n=113.
The reaction formula of pH response amphipathic nature polyalcohol molecule of the present invention as Figure 1-3.
(1) synthetic HO-PLA-OH(A:B:C=100:15:3, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (10 g, 91.32 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.15 mg, 1.37 parts) and initiator 1,4-butyleneglycol (0.8 g, 7.31 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 95 ℃ of oil baths, react 30 h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.
M n=1020，PDI=1.22。
(2) acrylated of HO-PLA-OH (AB:D:F=25:7:9, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(2.5 g, 61 parts) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.7 g, 17 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.9 g, 22 parts), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 20 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(3) acrylated of MPEG (macromonomer C:D:F=50:3:2, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 91.9 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.13 g, 4.78 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.09 g, 3.32 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 20 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=100:90:113:139, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(0.9 g, 20.36 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(1.13 g, 25.57 parts), TDP(1.39 g, 31.45 parts), A-PLA-A(1g, 22.62 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 70 ℃, magnetic agitation is reacted 70 h.Product usefulness, the solution that obtains slowly join and precipitate precipitation in three times in 0 ℃ of ether of 300 mL, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtain pale yellow powder.
M n=11374，PDI=1.25。Obtain the x=5 of product, y=3, n=113.
(1) synthetic HO-PLA-OH(A:B:C=300:5:1, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (30 g, 98.04 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.1 mg, 0.33 part) and initiator 1,4-butyleneglycol (0.5 g, 1.63 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 105 ℃ of oil baths, react 20 h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.
M n=2960，PDI=1.32。
(2) acrylated of HO-PLA-OH (AB:D:F=75:4:3.4, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(7.5 g, 91.02 part) be dissolved in the solution that forms 10 % in the methylene dichloride (75 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.4 g, 4.85 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.34 g, 4.13 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 20 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(3) acrylated of MPEG (macromonomer C:D:F=50:1:1, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 96.2 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.05 g, 1.9 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.05 g, 1.9 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 20 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=150:125:34:46, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(2.5 g, 35.21 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(0.68 g, 9.8 parts), TDP(0.92 g, 12.96 parts), A-PLA-A(3g, 42.25 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 55 ℃, magnetic agitation is reacted 80 h.Product usefulness, the solution that obtains slowly join and precipitate precipitation in three times in 0 ℃ of ether of 300 mL, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtain pale yellow powder.
M n=13540，PDI=1.36。Obtain the x=10 of product, y=1, n=113.
(1) synthetic HO-PLA-OH(A:B:C=300:5:3, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (30 g, 97.4 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.3 mg, 0.98 part) and initiator 1,4-butyleneglycol (0.5 g, 1.62 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 100 ℃ of oil baths, react 24 h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.
M n=2500，PDI=1.27。
(2) acrylated of HO-PLA-OH (AB:D:F=25:4:9, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(2.5 g, 65.78 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.4 g, 10.53 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.9 g, 23.68 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 24 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(3) acrylated of MPEG (macromonomer C:D:F=50:1:2, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 91.9 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.13g with syringe, 4.78 parts), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.09 g, 3.32 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 24h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=250:250:113:139, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(2.5 g, 33.24 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(1.13 g, 15.03 parts), TDP(1.39 g, 18.49 parts), A-PLA-A(2.5g, 33.24 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 60 ℃, magnetic agitation is reacted 75 h.Product usefulness, the solution that obtains slowly join and precipitate precipitation in three times in 0 ℃ of ether of 300 mL, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtain pale yellow powder.
M n=12552，PDI=1.38。Obtain the x=4 of product, y=2, n=113.
(1) synthetic HO-PLA-OH(A:B:C=100:15:3, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (10 g, 84.7 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.3 g, 2.6 parts) and initiator 1,4-butyleneglycol (1.5 g, 12.7 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 80 ℃ of oil baths, react 36h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.
M n=992，PDI=1.35。
(2) acrylated of HO-PLA-OH (AB:D:F=25:7:9, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(2.5 g, 61 parts) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.7 g, 17 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.9 g, 22 parts), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 36 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(3) acrylated of MPEG (macromonomer C:D:F=50:3:2, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 90.9 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.15g with syringe, 5.45 parts), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.1 g, 3.35 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 36 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=100:90:113:139, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(0.9 g, 20.36 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(1.13 g, 25.57 parts), TDP(1.39 g, 31.45 parts), A-PLA-A(1 g, 22.62 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 80 ℃, magnetic agitation is reacted 60 h.Product usefulness, the solution that obtains slowly join and precipitate precipitation in three times in 0 ℃ of ether of 300 mL, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtain pale yellow powder.
M n=10752，PDI=1.04。Obtain the x=4 of product, y=3, n=113.
(1) synthetic HO-PLA-OH(A:B:C=100:5:1, A represents the monomer rac-Lactide, and B represents initiator 1, and 4-butyleneglycol, C represent catalyst S n (Oct)
2, ratio is mass percent, down together).Stirrer and monomer rac-Lactide (20 g, 94.33 parts) are added in the 100 mL reaction flasks of band stirrer, bleed after the sealing-ventilate three times, under argon shield, add solvent toluene (40 mL) and catalyst S n (Oct) with syringe successively
2(0.2 g, 0.95 part) and initiator 1,4-butyleneglycol (1 g, 4.72 parts).Behind liquid nitrogen freezing, vacuumize-heat up-inflate three times, under argon shield, in 120 ℃ of oil baths, react 12 h.After reaction finishes, the solution that obtains is removed toluene through the decompression rotary evaporation, with chloroform polymer dissolution is obtained solution again, slowly join the freezing methanol (1:1 of 300 mL (being equivalent to 10 times of liquor capacities), v/v) precipitation in, behind deionized water wash 2 times, at 45 ℃ of following vacuum-drying 48 h, obtain the HO-PLA-OH product.
M n=1204，PDI=1.20。
(2) acrylated of HO-PLA-OH (AB:D:F=10:1:1.36, AB represents HO-PLA-OH, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with HO-PLA-OH(5 g, 80.9 part) be dissolved in the solution that forms 10 % in the methylene dichloride (50 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.5 g, 8.09 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.68 g, 11.01 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 12 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(3) acrylated of MPEG (macromonomer C:D:F=25:10:7, C represents MPEG, D represents reductive agent TEA, F represents acylating agent AC, down with).Get 50 dry mL reaction flasks of baking, with MPEG(2.5 g, 93.63 part) be dissolved in the solution that forms 10 % in the methylene dichloride (25 mL), place single necked round bottom flask, slowly drip anhydrous TEA(0.1 g, 3.75 parts with syringe), with ice-cooled to 0 ℃, under agitation dropwise drip AC(0.07 g, 2.62 part), at 0 ℃ of following reaction 2 h, rise to room temperature after, continue reaction 12 h, reacted solution adds dilute hydrochloric acid, and gained lower floor solution joins in 0 ℃ of normal hexane of 300 mL (being equivalent to 10 times of lower floor's liquor capacities) and precipitates, and filters, at 45 ℃ of following vacuum-drying 48 h, obtain white powder then.
(4) synthetic segmented copolymer MPEG-
b-(PLA-
Co-PAE) (ABF:EF:G:H=20:25:9.05:11.57, ABF represent the product A-PLA-A of step (2), and EF represents the product MPEG-A of step (3), and G represents diacrylate HDD, and H represents diamines TDP, down together).With MPEG-A(2.5 g, 41.81 parts) add in the 100 mL single port reaction flasks, freezing after the sealing-as to vacuumize-the Tong argon gas, three times, under argon shield, add anhydrous chloroform (10 mL) dissolving, freezing-as to vacuumize-the Tong argon gas, three times.Respectively with certain amount of H DD(1.13 g, 18.9 parts), TDP(1.35 g, 22.57 parts), A-PLA-A(1 g, 16.72 parts) be dissolved in the anhydrous chloroform (10 mL), mix then, mixed solution is joined in the reaction flask with syringe, under 50 ℃, magnetic agitation is reacted 80 h.Product usefulness, the solution that obtains slowly join in 0 ℃ of ether of 300 mL and precipitate three times, after the filtration, at 35 ℃ of following vacuum-drying 48 h, obtain pale yellow powder.
M n=14536，PDI=1.53。Obtain the x=2 of product, y=6, n=113.
The fluorescent probe method is measured embodiment 1 product MPEG-
b-(PLA-
Co-PAE) micelle-forming concentration.
(1) preparation pyrene solution: pyrene is mixed with 6*10 with acetone
-5The solution of M.
(2) join sample solution: take by weighing 10 mg MPEG-
b-(PLA-
Co-PAE) be dissolved in 5 mL acetone, dropwise join in the 100 mL deionized waters, obtain 0.1 mg/mL solution behind the volatilization acetone, be diluted to a series of concentration (0.0001 ~ 0.1 mg/ml) subsequently.Get 20 10 mL volumetric flasks, every adds 0.1 mL pyrene solution, and the polymers soln that adds above-mentioned different concns then respectively is made into sample liquid.The concentration of pyrene is 6*10 in the sample liquid
-7M.
(3) fluorescence spectrum test: as emission wavelength, specimen liquid is got at the excitation spectrum of 300-350nm with 373 nm
I 337/
I 336Ratio is seen Figure 10 to concentration logarithm logC mapping, and curve break is the micelle-forming concentration value.Record MPEG-
b-(PLA-
Co-PAE) micelle-forming concentration is 1.5 mg/L.
Preparation MPEG-
b-(PLA-
Co-PAE) blank micella, and characterize the situation that its particle diameter and current potential change with pH.Adopt dialysis method to prepare blank micella.Accurately take by weighing 40 mg MPEG-
b-(PLA-
Co-PAE) be dissolved in the 50 mL dimethyl formamides, stir 2h under the room temperature, change dialysis tubing (MWCO3500 ~ 4000) over to, with 1 L deionized water, 48 h that dialyse, preceding 12 h, per 2 h change the medium of once dialysing, and back 36 h do not have 6 h to change the medium of once dialysing.Be that the filtering head of 0.8 μ m filters postlyophilization with the micellar solution via hole diameter.Blank micella is added in the pre-assigned different pH buffered soln successively, place 0.5 h.Adopt dynamic light scattering method to survey MPEG-
b-(PLA-
Co-PAE) particle diameter and current potential be with the variation of pH value.See Figure 11 and Figure 12.
Adopt dialysis method to prepare carrier micelle.Accurately take by weighing 20 mg Zorubicins, 40 mg MPEG-b-(PLA-co-PAE) are dissolved in the 50 mL dimethyl formamides, drip TEA(0.02 mL) after stirring 2 h under the room temperature, change dialysis tubing (MWCO3500 ~ 4000) over to, with 1 L deionized water, 48 h that dialyse, preceding 12 h, per 2 h change the medium of once dialysing, back 36 h do not have 6 h to change the medium of once dialysing.Be that the filtering head of 0.8 μ m filters postlyophilization with the micellar solution via hole diameter.Adopt SEM to observe its pattern for spherical, see Figure 13.
Extracorporeal releasing experiment: accurately take by weighing 3 mg carrier micelle powder, place dialysis tubing (MWCO3500 ~ 4000), (pH 5.0 to add 3 mL PBS buffered soln then respectively, 6.5 and 7.4), seal dialysis tubing, change medicament dissolution instrument over to, add 40 mL PBS damping fluids.Design temperature is at 37 ℃, and stirring velocity is 110 rpm.3 mL that take a sample at regular intervals, and add 3 mL fresh buffer.Discharge doxorubicin concentration in the liquid with the determined by ultraviolet spectrophotometry different time, draw its release in vitro curve.
Figure 14 is MPEG-
b-(PLA-
Co-PAE) the release in vitro curve of (embodiment 1 product), in home (pH 7.4), drug releasing rate is all very slow: 3 h discharge and are lower than 20%, 148 h and discharge and be lower than 36%, effectively protect the loss of medicine in the blood of human body working cycle.In weakly acidic condition (pH 6.5), MPEG-
b-(PLA-
Co-PAE) carrier micelle just discharges 25%, 30 h at 2.5 h and has discharged 50%, 148 h and discharge 66%; Acid reinforcement (pH 5.0), the MPEG-of continuing
b-(PLA-
Co-PAE) carrier micelle just discharges 38%, 24 h at 1.5 h and has discharged 62%, 148 h and discharge near 90%.
Embodiment 11
Cytotoxicity experiment: the HepG2 cell is tiled on 96 orifice plates by 1 * 104 density, adds 200 μ L nutrient solutions, cultivate 24 h.With certain density free Zorubicin, blank micella and carrier micelle interpolation enter in the orifice plate, upgrade developing medium.3 skies of the parallel repetition of each concentration.Blank is put into the ovum device, and 5 % CO2 and 37 ° of C keep 24 h and 48 h respectively.Replace the orifice plate medium with 180 μ L fresh mediums and 20 μ L MTT solution, continue ovumization 4 h, replace the orifice plate medium with 200 μ L DMSO.Orifice plate is placed on vibration 15 min in 37 ° of C shaking tables, utilizes microplate reader to measure the absorbance A that 490 nm go out each hole then, calculate cell survival rate, estimate its cytotoxicity.
Figure 15 is blank MPEG-
b-(PLA-
Co-PAE) cytotoxicity figure.As seen from the figure, along with the increase of block polymerization substrate concentration, cell survival rate has slight decline, when polymer concentration was 400mg/L, case study on implementation 1,2 cell survival rate corresponding with 3 products was 96.08 %, 95.14 % and 92.95% illustrate that this block polymer is almost non-toxic.Figure 16 and Figure 17 are the cytotoxicity figure behind three case study on implementation product carrier micelles and free Zorubicin 24 h and 48 h.As seen from the figure, behind 24 h and 48 h, cell survival rate is 50 %(IC50) concentration of corresponding free DOX and carrier micelle is respectively 1.5 mg/L, 3.0mg/L, 1.8mg/L, 5.35mg/L and 0.42 mg/L, 1.0mg/L, 0.8mg/L, 1.75mg/L.
Claims (8)
1. the pH response random copolymers based on poly--β amino ester is characterized in that structural formula is
x=2～10，y=1～6，n=113。
2. the pH response random copolymers based on poly--β amino ester according to claim 1 is characterized in that the number-average molecular weight of described multipolymer is 10752～14536g/mol.
3. the preparation method of the described pH response random copolymers based on poly--β amino ester of claim 1 is characterized in that, may further comprise the steps:
(1) preparation macromonomer A: under protection of inert gas and anhydrous condition, with monomer, catalyst system A, initiator and solvent, at 80～120 ℃ of reaction 12～36h down, remove solvent after, precipitation, filtration, drying obtain macromonomer A; (2) preparation macromonomer B: macromonomer A is dissolved in the solvent, add reductive agent, be cooled to 0 ℃, add acylating agent then, keep 0 ℃ to rise to behind the reaction 2h down and react 12～36h under the room temperature again, then the macromonomer B after precipitation, filtration, dry terminal hydroxyl acrylated;
(3) preparation macromonomer D: hydrophilic macromonomer C is dissolved in the solvent, add reductive agent, be cooled to 0 ℃, add acylating agent then, keep 0 ℃ to rise to behind the reaction 2h down and react 12～36h under the room temperature again, then the macromonomer D after precipitation, filtration, dry terminal hydroxyl acrylated;
(4) preparation responds linear random copolymer based on the pH of poly--β amino ester: the macromonomer B that respectively macromonomer D, diacrylate, diamines and step (2) is obtained under protection of inert gas and anhydrous condition is dissolved in the solvent, the mixing back is reacted 60～80h down at 50～80 ℃, and precipitation, filtration, oven dry obtain pH response linear random copolymer;
The parts by weight of reactant are as follows in the described step (1):
84.7～98.04 parts of monomers
0.33～2.6 part of catalyst system A
1.62～12.7 parts of initiators;
The parts by weight of reactant are as follows in the described step (2):
61～91.32 parts of macromonomer A
4.8～17 parts of reductive agents
4.13～23.68 parts of acylating agents;
The parts by weight of reactant are as follows in the described step (3):
90.9～96.2 parts of hydrophilic macromonomer C
1.9～5.45 parts of reductive agents
1.9～3.35 parts of acylating agents;
The parts by weight of reactant are as follows in the described step (4):
Described monomer is D, the L-rac-Lactide;
Described diamines is 1,3-pair-4-piperidines propane;
Described diacrylate is 1,6 hexanediol diacrylate;
Described hydrophilic macromonomer C is mono methoxy polyethylene glycol, and its structural formula is as follows:
N=113 wherein.
4. preparation method according to claim 3 is characterized in that, catalyst system A is the toluene solution of stannous octoate described in the step (1);
The described initiator of step (1) is 1,4-butyleneglycol;
The described solvent of step (1) is toluene or methyl-phenoxide;
Step (2) and (3) described reductive agent are triethylamine;
Step (2) and (3) described acylating agent are acrylate chloride;
Step (2) and (3) described solvent are methylene dichloride;
The described solvent of step (4) is chloroform.
5. preparation method according to claim 4 is characterized in that, step (1) is described, and to remove solvent be with the reaction product rotary evaporation desolventizing of reducing pressure;
Precipitation described in the step (1) is that the product that will remove behind the solvent is dissolved in chloroform or the methylene dichloride, solution is joined in the mixing solutions of 0 ℃ of cold methanol being equivalent to 10 times of its volumes and water again, and cold methanol and water volume ratio are 1:1;
Step (2) and (3) described precipitation are that reacted solution is joined in the 0 ℃ of cold normal hexane that is equivalent to 10 times of its volumes; The described precipitation of step (4) is that reacted solution is joined in the 0 ℃ of cold diethyl ether that is equivalent to 10 times of its volumes.
6. the micelle medicine carrying system of the described poorly water soluble drugs that makes based on the pH response random copolymers of poly--β amino ester of claim 1.
7. the preparation method of the micelle medicine carrying system of the described poorly water soluble drugs of claim 6, it is characterized in that, be to be dissolved in the organic solvent based on pH response random copolymers and the poorly water soluble drugs of poly--β amino ester, use pH damping fluid dialysis 24h postlyophilization after stirring 6h, obtain, described organic solvent is dimethyl formamide or dimethyl sulfoxide (DMSO) or acetone, and described pH damping fluid is the buffered soln of pH value 7～9.
8. the micelle medicine carrying system of the described poorly water soluble drugs of claim 6 carries and APPLICATION IN TRANSMISSION at the bag of slightly water-soluble cancer therapy drug.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210087875 CN102627767B (en) | 2012-03-29 | 2012-03-29 | Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210087875 CN102627767B (en) | 2012-03-29 | 2012-03-29 | Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102627767A CN102627767A (en) | 2012-08-08 |
| CN102627767B true CN102627767B (en) | 2013-09-25 |
Family
ID=46586177
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210087875 Expired - Fee Related CN102627767B (en) | 2012-03-29 | 2012-03-29 | Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102627767B (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103709343B (en) * | 2013-12-16 | 2016-08-17 | 三棵树涂料股份有限公司 | One has pH/ temperature/light triple response block polymer and preparation method thereof |
| CN104974353B (en) * | 2015-07-02 | 2017-08-25 | 华南理工大学 | PH response three block linear polymers and micellar system based on poly- β amidos ester |
| CN105131182B (en) * | 2015-09-06 | 2017-07-21 | 山东大学 | Poly- (β amino esters) polymer of pluronic and its synthesis and methods for using them |
| CN106317416B (en) * | 2016-09-07 | 2019-06-07 | 国家纳米科学中心 | A kind of amphipathic copolymer and its preparation method and application of double pH responses |
| CN108363901A (en) * | 2018-02-08 | 2018-08-03 | 中国石油大学(华东) | A kind of analogy method of pH response types block copolymer PAE-PEG loadings and release naphthalene molecule |
| CN110746599B (en) * | 2019-09-30 | 2021-06-18 | 苏州大学 | UV (ultraviolet) light-responsive hyperbranched poly-beta-amino ester with high-efficiency gene delivery capacity as well as preparation method and application thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7229973B2 (en) * | 2002-05-19 | 2007-06-12 | You Han Bae | pH-sensitive polymeric micelles for drug delivery |
| FR2846973B1 (en) * | 2002-11-07 | 2004-12-17 | Rhodia Chimie Sa | ANTI-WRINKLE COMPOSITION COMPRISING A COPOLYMER WITH CONTROLLED ARCHITECTURE FOR TEXTILE FIBER ARTICLES |
| CN101121771A (en) * | 2006-08-11 | 2008-02-13 | 汉高股份两合公司 | Acryloxyalkoxysilicane modified acrylic acid ester polymerization emulsion and its preparation method and application |
| WO2008112565A2 (en) * | 2007-03-09 | 2008-09-18 | Anthony Manganaro | Method and composition for treating cancer |
| CN102225204B (en) * | 2011-06-09 | 2013-02-13 | 天津工业大学 | Anti-tumour pH sensitive slow release implant and preparation method thereof |
-
2012
- 2012-03-29 CN CN 201210087875 patent/CN102627767B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102627767A (en) | 2012-08-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106265509B (en) | A kind of pH and Redox double-bang firecracker answers amphipathic nature block polymer and its preparation method and application | |
| Chen et al. | Folic acid grafted and tertiary amino based pH-responsive pentablock polymeric micelles for targeting anticancer drug delivery | |
| CN102627767B (en) | Potential of hydrogen (pH) response random copolymer based on poly-beta amino ester and preparation method and application thereof | |
| Chaw et al. | Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides:: drug incorporation and in vitro release | |
| Chen et al. | pH-dependent, thermosensitive polymeric nanocarriers for drug delivery to solid tumors | |
| CN102633959B (en) | PH-responsive comb-like copolymer and preparation and application thereof | |
| Lin et al. | Amphiphilic miktoarm star copolymer (PCL) 3-(PDEAEMA-b-PPEGMA) 3 as pH-sensitive micelles in the delivery of anticancer drug | |
| Sun et al. | Novel reduction-sensitive micelles for triggered intracellular drug release | |
| CN103333301B (en) | Amphiphilic pH-responsive 4/6 heteroarm star-shaped copolymer and preparation method thereof | |
| CN101891870B (en) | Amphiphilic copolymer brush with pH responsiveness, preparation method thereof and use thereof | |
| Li et al. | Novel stimuli-responsive micelle self-assembled from Y-shaped P (UA-Y-NIPAAm) copolymer for drug delivery | |
| CN104231155A (en) | Cholesterol modified amphiphilic pH response pennicuius copolymer as well as preparation and micelle of copolymer | |
| Lu et al. | Acetals moiety contained pH-sensitive amphiphilic copolymer self-assembly used for drug carrier | |
| CN103554508B (en) | Acid-sensitive amphipathic star-block copolymers, its preparation method and application | |
| CN102702454A (en) | PH response four-arm star block copolymer and preparation method and application thereof | |
| CN102432783B (en) | PH response/hydrophobic group random copolymerization polymer, and preparation method and application thereof | |
| Ju et al. | A biodegradable polyphosphoester-functionalized poly (disulfide) nanocarrier for reduction-triggered intracellular drug delivery | |
| CN102702453A (en) | pH-responsive 6-arm star block copolymer and preparation method and application thereof | |
| CN106474049B (en) | A kind of photopolymerized hydrogel topical drug delivery systems and preparation method and application | |
| Kalva et al. | Degradable pH-responsive polymer prodrug micelles with aggregation-induced emission for cellular imaging and cancer therapy | |
| CN105131182A (en) | Pluronic-poly(beta-amino ester) polymer and synthesis and application methods | |
| Wei et al. | Temperature-and pH-sensitive core-shell nanoparticles self-assembled from poly (n-isopropylacrylamide-co-acrylic acid-co-cholesteryl acrylate) for intracellular delivery of anticancer drugs | |
| CN104387591B (en) | A kind of hydrophilic polyglycol hydrophobicity poly phosphate block copolymer and its production and use | |
| CN107823184B (en) | Preparation method and application of redox sensitive induced pH response nano-drug carrier | |
| CN106562926B (en) | A kind of K+Response type amphipathic stem block copolymer carrier micelle and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130925 Termination date: 20210329 |